1-(5-(3-Chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one

ID: ALA4556131

PubChem CID: 122703644

Max Phase: Preclinical

Molecular Formula: C14H17ClN2O

Molecular Weight: 264.76

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(C)C(=O)N1N=CCC1c1cccc(Cl)c1

Standard InChI:  InChI=1S/C14H17ClN2O/c1-14(2,3)13(18)17-12(7-8-16-17)10-5-4-6-11(15)9-10/h4-6,8-9,12H,7H2,1-3H3

Standard InChI Key:  CBDZTOOXTCLDDB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
    3.9417   -5.3044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7668   -5.3044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0236   -4.5202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3543   -4.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6892   -4.5202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8086   -4.2663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4210   -4.8193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9812   -3.4596    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2482   -5.6260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2059   -4.5654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0002   -5.4002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3530   -3.2086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0685   -2.7955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0676   -1.9713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3520   -1.5591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6357   -1.9771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6402   -2.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7817   -1.5581    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  3  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  1  0
  7 10  1  0
  7 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  4 12  1  0
 14 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4556131

    ---

Associated Targets(Human)

RIPK1 Tchem Receptor-interacting serine/threonine-protein kinase 1 (1548 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 264.76Molecular Weight (Monoisotopic): 264.1029AlogP: 3.65#Rotatable Bonds: 1
Polar Surface Area: 32.67Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.47CX LogP: 3.39CX LogD: 3.39
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: -1.02

References

1. Harris PA, Faucher N, George N, Eidam PM, King BW, White GV, Anderson NA, Bandyopadhyay D, Beal AM, Beneton V, Berger SB, Campobasso N, Campos S, Capriotti CA, Cox JA, Daugan A, Donche F, Fouchet MH, Finger JN, Geddes B, Gough PJ, Grondin P, Hoffman BL, Hoffman SJ, Hutchinson SE, Jeong JU, Jigorel E, Lamoureux P, Leister LK, Lich JD, Mahajan MK, Meslamani J, Mosley JE, Nagilla R, Nassau PM, Ng SL, Ouellette MT, Pasikanti KK, Potvain F, Reilly MA, Rivera EJ, Sautet S, Schaeffer MC, Sehon CA, Sun H, Thorpe JH, Totoritis RD, Ward P, Wellaway N, Wisnoski DD, Woolven JM, Bertin J, Marquis RW..  (2019)  Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase.,  62  (10): [PMID:31013427] [10.1021/acs.jmedchem.9b00318]

Source